SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VD's Model Portfolio & Discussion Thread
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Rocketman who started this subject9/15/2000 2:53:54 PM
From: Don Miller  Read Replies (1) of 9719
 
I have been in SEPR for about two years now and have remained both interested and concerned about Anti-IgE alternatives. So much so I sought out Tanox (TNOX) months before it became public this spring. They now have some interesting results, some of which I have collected links to at Message 14392430. I would post the text here but copying is cutting off the ends of the links.

Richard, I remember a year ago you advising me that you commented somewhere on Anti-IgE. Should I be looking somewhere else for Anti-IgE or Tanox? I am still trying to confirm when the BLA was submitted and when could we expect FDA approval.

Is the treatment method practical? What does anybody judge the applicability of Anti-IgE approach to be?

What do you think of TNOX for your portfolio?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News